The American Society of Hematology (ASH) has appointed Dr. Catherine Bollard, the Director of the Centre for Cancer and Immunology Research at the Children’s National Research Institute, as the next editor-in-chief of its journal Blood Advances, effective September 2021.
Blood Advances is a peer-reviewed online open access journal published by ASH that covers the latest developments in basic, translational, and clinical hematology. Dr. Bollard was selected by the ASH Executive Committee after a competitive international search.
Since its launch in 2016, Blood Advances has taken advantage of its digital, open-access publication model to emphasise multimedia and a rapid, continuous publication format. Under the leadership of founding editor-in-chief Robert Negrin of Stanford University, the peer-reviewed journal has pioneered new means of interactive, collaborative discussion and achieved an impact factor of 4.910.
Dr. Bollard is a hematologist whose research interests include developing cell and gene therapies for patients with cancer and underlying immune deficiencies. Recognised as a national and international leader in the bone marrow transplant, immunology and immunotherapy space, Dr. Bollard has an expansive understanding of cancer, immune deficiencies, and viral infections in pediatric and adult patients.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
Click here to read the original press release.
